Saflutan eye drops (Tafluprost) is a preservative free prostaglandin analogue indicated for patients with elevated IOP in open-angle glaucoma or ocular hypertension.1
Patients treated with preservative eye drops may develop Ocular Surface Disease (OSD) such as irritation, burning, itching, tearing or dry eye sensation, which can impact quality of life. Using preservative free treatments such as Saflutan eye drops can lower the risk of developing OSD.2
Saflutan eye drops deliver:
- Reduced IOP from between two and four hours after the first administration, with maximum effect reached at around 12 hours after instillation. The effect is maintained for at least 24 hours3
- Significantly improved ocular symptoms and signs in patients switched from latanoprost4
Saflutan eye drops are available as a sterile, preservative-free solution in single-dose containers (0.3ml) containing 4.5 micrograms of tafluprost (0.0015 per cent).1 The eye drops are listed on the PBS as a drug for open-angle glaucoma or ocular hypertension.
Using preservative free treatments such as Saflutan eye drops can lower the risk of developing OSD
Contact: Mundipharma (AUS) 1800 188 009
References
1. Saflutan eye drops Product Information, April 2016
2. Perez-Roca F, Rodrigo-Morales E, Garzon I, et al. Effects of four formulations of prostaglandin analogs on eye surface cells. A comparative study. PLoS One. 2015;10(6):e0129419. doi: 10.1371/journal.pone.0129419.
3. Uusitalo H, Pillunat LE, Ropo A. Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomised, double-masked phase III study. Acta Ophthalmol. 2010;88:12-19.
4. Uusitalo H, Chen E, Pfeiffer N, et al. Switching from a preserve to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta Ophthalmol. 2010;88:329-336.
